JP2022536408A5 - - Google Patents

Info

Publication number
JP2022536408A5
JP2022536408A5 JP2022515975A JP2022515975A JP2022536408A5 JP 2022536408 A5 JP2022536408 A5 JP 2022536408A5 JP 2022515975 A JP2022515975 A JP 2022515975A JP 2022515975 A JP2022515975 A JP 2022515975A JP 2022536408 A5 JP2022536408 A5 JP 2022536408A5
Authority
JP
Japan
Prior art keywords
patent document
application
application publication
document
prior
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022515975A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022536408A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/034273 external-priority patent/WO2020237172A1/en
Publication of JP2022536408A publication Critical patent/JP2022536408A/ja
Publication of JP2022536408A5 publication Critical patent/JP2022536408A5/ja
Priority to JP2025034659A priority Critical patent/JP2025093991A/ja
Pending legal-status Critical Current

Links

JP2022515975A 2019-05-23 2020-05-22 アルコール誘発性皮膚紅潮の治療および緩和のための組成物および方法 Pending JP2022536408A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025034659A JP2025093991A (ja) 2019-05-23 2025-03-05 アルコール誘発性皮膚紅潮の治療および緩和のための組成物および方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962852000P 2019-05-23 2019-05-23
US62/852,000 2019-05-23
PCT/US2020/034273 WO2020237172A1 (en) 2019-05-23 2020-05-22 Compositions and methods for the treatment and mitigation of alcohol-induced skin flushing

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025034659A Division JP2025093991A (ja) 2019-05-23 2025-03-05 アルコール誘発性皮膚紅潮の治療および緩和のための組成物および方法

Publications (2)

Publication Number Publication Date
JP2022536408A JP2022536408A (ja) 2022-08-15
JP2022536408A5 true JP2022536408A5 (enExample) 2023-05-08

Family

ID=73458156

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022515975A Pending JP2022536408A (ja) 2019-05-23 2020-05-22 アルコール誘発性皮膚紅潮の治療および緩和のための組成物および方法
JP2025034659A Pending JP2025093991A (ja) 2019-05-23 2025-03-05 アルコール誘発性皮膚紅潮の治療および緩和のための組成物および方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025034659A Pending JP2025093991A (ja) 2019-05-23 2025-03-05 アルコール誘発性皮膚紅潮の治療および緩和のための組成物および方法

Country Status (7)

Country Link
US (1) US20220226286A1 (enExample)
EP (1) EP3973030A4 (enExample)
JP (2) JP2022536408A (enExample)
KR (1) KR20220012903A (enExample)
CN (2) CN114144493A (enExample)
TW (1) TW202110437A (enExample)
WO (1) WO2020237172A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102879756B1 (ko) 2022-11-11 2025-11-12 대한민국 이상지질혈증 예측 또는 진단용 snp 마커 및 이의 용도
KR102893400B1 (ko) 2022-11-21 2025-12-02 대한민국 당뇨병 예측 또는 진단용 hectd4 snp 마커 및 이의 용도

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6468319A (en) * 1987-09-09 1989-03-14 Nonogawa Shoji Yk Anti-inflammatory
JPH01287035A (ja) * 1988-05-13 1989-11-17 Sanwa Kagaku Kenkyusho Co Ltd 薬物並びにアルコール性中毒の予防剤とその治療剤
TW271400B (enExample) * 1992-07-30 1996-03-01 Pfizer
IT1306133B1 (it) * 1999-04-22 2001-05-30 Sigma Tau Healthscience Spa Composizione comprendente una carnitina ed un inositolfosfato, utilequale integratore dietetico o medicamento.
US6419956B1 (en) * 1999-12-30 2002-07-16 Ancile Pharmaceuticals Odor-masking coating for a pharmaceutical preparation
US20110053999A1 (en) * 2004-03-03 2011-03-03 Daley Thomas E 4-methylpyrazole formulations for inhibiting ethanol intolerance
DK1909600T3 (da) * 2005-07-29 2012-07-30 Tima Foundation Sammensætning til moderering af alkoholmetabolisme og til at reducere risikoen for alkoholforårsagede sygdomme
US20110105602A2 (en) * 2007-03-08 2011-05-05 Daria Mochly-Rosen Mitochondrial Aldehyde Dehydrogenase-2 Modulators and Methods of Use Thereof
JP2011051942A (ja) * 2009-09-03 2011-03-17 Glovia:Kk 認知症治療薬
CN102549171A (zh) * 2009-10-07 2012-07-04 学校法人武库川学院 基因型的判断方法
ES2646201T3 (es) * 2009-12-07 2017-12-12 Horizon Orphan Llc Formulaciones de 4-metilpirazol
WO2012027326A2 (en) * 2010-08-24 2012-03-01 The Regents Of The University Of California Methods of treating alcohol intoxication, alcohol use disorders and alcohol abuse which comprise the administration of dihydromyricetin
FI128082B (en) * 2014-09-15 2019-09-13 Biohit Oyj Preparations for the treatment and prevention of alcohol redness and alcohol-induced hypersensitivity reactions
EP3323412A1 (en) * 2016-11-17 2018-05-23 Amalicon Holding AG Formulation comprising 4-methylpyrazole

Similar Documents

Publication Publication Date Title
JP2021524958A5 (enExample)
JP2019502892A5 (enExample)
JP2023502438A5 (enExample)
JP2022510882A5 (enExample)
JP2021511664A5 (enExample)
JP2014528601A5 (enExample)
JP2022521336A5 (enExample)
JP2014513356A5 (enExample)
JP2023021979A5 (enExample)
JP2013540292A5 (enExample)
JP2012504317A5 (enExample)
JP2013519136A5 (enExample)
JP2022534782A5 (enExample)
JP2016506003A5 (enExample)
JP2023527970A5 (enExample)
JP2023553310A5 (enExample)
JP2014502322A5 (enExample)
JP2018525453A5 (enExample)
CN111655682A (zh) 一种高活性sting蛋白激动剂化合物
JP2014520155A5 (enExample)
JP2021505241A5 (enExample)
JP2022525049A5 (enExample)
JP2020512939A5 (enExample)
JP2022536408A5 (enExample)
JP2015508925A5 (enExample)